Abivax SA(GB:0RA9)
€79.10-3.40 (-4.12%)
GB:0RA9
Abivax SA financials statements
€79.10
At close:-3.40 (-4.12%)
Abivax SA (0RA9) Financial Statements
0 Followers
Abivax SA Financial Overview
Abivax SA's market cap is currently €6.93B. The company's EPS TTM is €-4.71; its P/E ratio is -16.79; Abivax SA is estimated to report earnings on December 14, 2026, and the estimated EPS forecast is €-0.81. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € 0.00 | € 10.79M | € 4.62M | € 4.58M | € 37.00K |
| Gross Profit | € -1.07M | € 10.79M | € 4.49M | € 4.51M | € -119.00K |
| Operating Income | € -250.63M | € -185.43M | € -127.38M | € -64.84M | € -52.19M |
| EBITDA | € -249.55M | € -167.68M | € -133.21M | € -53.31M | € -42.20M |
| Net Income | € -336.10M | € -176.24M | € -147.74M | € -60.74M | € -42.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | € 530.38M | € 144.22M | € 260.99M | € 26.95M | € 60.70M |
| Total Assets | € 584.34M | € 205.23M | € 327.06M | € 73.35M | € 110.36M |
| Total Debt | € 32.09M | € 97.36M | € 55.46M | € 39.16M | € 53.45M |
| Net Debt | € -484.59M | € -46.86M | € -196.48M | € 19.78M | € -7.25M |
| Total Liabilities | € 129.14M | € 164.64M | € 131.05M | € 71.47M | € 81.59M |
| Stockholders' Equity | € 455.20M | € 40.58M | € 196.01M | € 7.19M | € 25.93M |
| Cash Flow | |||||
| Free Cash Flow | € -162.23M | € -154.72M | € -97.39M | € -69.55M | € -47.30M |
| Operating Cash Flow | € -162.09M | € -154.07M | € -97.13M | € -65.58M | € -45.66M |
| Investing Cash Flow | € -13.72M | € 15.76M | € -8.10M | € -3.73M | € -1.46M |
| Financing Cash Flow | € 553.80M | € 28.21M | € 335.29M | € 32.21M | € 82.68M |
Currency in EUR

